Compounded semaglutide vs brand name Wegovy: what is the real difference?

Short answer

• Wegovy (semaglutide, made by Novo Nordisk) is an FDA‑approved, clinically tested, prefilled‑pen product for weight loss with strict manufacturing and labeling controls.
• “Compounded semaglutide” is a preparation made by a compounding pharmacy from raw active ingredient and is not FDA‑approved as a finished drug — it can be less expensive but carries real quality, potency and sterility risks.

Key differences (what actually matters)

1. Regulatory status and evidence

   • Wegovy: FDA approved for chronic weight management at labeled doses (2.4 mg weekly). Approval means clinical trials on safety and efficacy and ongoing oversight.
   • Compounded: Not FDA‑approved as a finished product. Compounded versions don’t come with Wegovy’s large, controlled clinical‑trial safety/efficacy data for that specific formulation and delivery system.

2. Manufacturing quality and testing

   • Wegovy: Manufactured by Novo Nordisk under pharmaceutical GMPs with batch testing and lot traceability.
   • Compounded: Quality depends on the pharmacy. Some do excellent sterile work; others may have variable potency, contamination risk, incorrect excipients, or unstable concentrations.

3. Sterility and safety

   • Wegovy pens are designed for multi‑dose use and are manufactured sterile.
   • Compounded vials or syringes must be sterile‑compounded under USP <797> conditions — if not, there’s risk of infection or particulate contamination.

4. Dose accuracy and devices

   • Wegovy: comes in calibrated, prefilled pens with dose escalation instructions and consistent delivery.
   • Compounded: may be supplied in vials or prefilled syringes (or in some cases pens made by third parties). Accuracy, ramp‑up dosing, and device reliability vary.

5. Labeling, instructions, follow‑up

   • Wegovy includes full prescribing info, known side‑effect profile, and post‑marketing safety monitoring.
   • Compounded products typically have less standardized labeling and you’ll have fewer regulatory protections if something goes wrong.

6. Cost and access

   • Wegovy is expensive; coverage varies. Novo Nordisk has support programs.
   • Compounded semaglutide is often cheaper and may be paid out‑of‑pocket, which is why many people choose it despite the risks.

When a compounded product might be reasonable

• If Wegovy is unaffordable or unobtainable and:
  • you work with a reputable, accredited compounding pharmacy that sterily compounds GLP‑1 injectables,
  • the pharmacy can provide certificates of analysis (COAs), sterility/ endotoxin testing, API source documentation, expiration/stability data and lot traceability,
  • your prescriber documents benefits/risks and is experienced with GLP‑1 therapy.

What to ask / check if you consider compounded semaglutide

• Is the pharmacy accredited (PCAB or ACHC) and do they comply with USP <797> sterile compounding?
• Can they provide a recent COA and sterility test results for your lot?
• What is the source of the active pharmaceutical ingredient (API)?
• How is it dosed and which delivery device is supplied? What training comes with it?
• What is their return and adverse‑event policy?

Practical alternatives / resources (specific names)

• Wegovy (Novo Nordisk) — recommended if you want an FDA‑approved option with known safety/efficacy and a manufactured pen device.
• Ozempic (semaglutide, Novo Nordisk) or Rybelsus (oral semaglutide) — approved for diabetes; sometimes discussed with clinicians for weight management under medical supervision (different approvals/labels).
• Zepbound (tirzepatide, Eli Lilly) — FDA approved for weight loss (different drug class but similar clinical effect).
• Novo Nordisk OneSupport — manufacturer patient support and savings program for Wegovy (helps with cost/insurance navigation).
• GoodRx — price comparison and coupons that sometimes reduce Wegovy/Ozempic costs.
• Look for compounding pharmacies accredited by PCAB or ACHC and following USP <797> — ask the pharmacy directly for accreditation and COAs.

My short recommendation

• If your priority is proven safety, consistent dosing, regulatory protection and device reliability: choose Wegovy (Novo Nordisk) if you can afford it or get coverage/help via OneSupport.
• If cost is prohibitive and you consider compounded semaglutide, only use a highly reputable, accredited compounding pharmacy, get documentation (COA, sterility), and discuss risks with your prescribing clinician.

If you want, tell me:

• whether you’re comparing prices/insurance coverage or researching safety, and I can point to patient assistance resources and how to evaluate specific compounding pharmacies near you.